VERACYTE, INC.·4

Jun 4, 5:00 PM ET

Febbo Phillip G. 4

4 · VERACYTE, INC. · Filed Jun 4, 2025

Insider Transaction Report

Form 4
Period: 2025-06-02
Febbo Phillip G.
Chief Scientific & Med Officer
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2025-06-02$26.74/sh2,955$79,017103,745 total
Footnotes (1)
  • [F1]The reporting person is reporting the withholding of 1,688 and 1,267 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 3,324 and 2,494 Restricted Stock Units, respectively, granted on October 2, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person.
Signature
/s/ Jonathan Wygant, as attorney-in-fact|2025-06-04

Documents

1 file
  • 4
    wk-form4_1749070838.xmlPrimary

    FORM 4